Brian Kirby
University College Dublin(IE)Novartis (Switzerland)(CH)Bristol-Myers Squibb (Germany)(DE)Eli Lilly (United States)(US)Pfizer (United Kingdom)(GB)Leo Pharma (Australia)(AU)Janssen (France)(FR)Institute of Public Health(IE)Samsung (United States)(US)St. Vincent's University Hospital(IE)Galderma (France)(FR)Boehringer Ingelheim (India)(IN)Almirall (Spain)(ES)Institute of Dermatology(TH)NIHR Manchester Biomedical Research Centre(GB)University of Tartu(EE)
Publications by Year
Research Areas
Psoriasis: Treatment and Pathogenesis, Hidradenitis Suppurativa and Treatments, Dermatology and Skin Diseases, Colorectal and Anal Carcinomas, Autoimmune Bullous Skin Diseases
Most-Cited Works
- → A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1(2010)1,051 cited
- → The ‘psoriatic march’: a concept of how severe psoriasis may drive cardiovascular comorbidity(2011)503 cited
- → Diagnostic delay in hidradenitis suppurativa is a global problem(2015)382 cited
- → Sofosbuvir and Ribavirin for Treatment of Compensated Recurrent Hepatitis C Virus Infection After Liver Transplantation(2014)341 cited
- → High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires(2012)305 cited
- → Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa(2015)294 cited